Saxena White P.A. Files Securities Fraud Class Action Against Enzymotec Ltd.

BOCA RATON, FL--(Marketwired - Oct 1, 2014) -  Saxena White P.A. has filed a securities fraud class action lawsuit in the United States District Court for the District of New Jersey against Enzymotec Ltd. ("Enzymotec" or the "Company") (NASDAQ: ENZY) and certain of the Company's directors, officers and underwriters on behalf of investors who purchased or otherwise acquired the common stock of the Company during the period from March 27, 2013 through August 4, 2014 (the "Class Period"), including investors who purchased shares pursuant and/or traceable to the Company's initial public offering ("IPO") on or about September 27, 2013. 

Enzymotec produces specialty chemicals. The Company develops and manufactures nutritional ingredients and medicals foods and operates in both the nutrition and pharmaceutical industries.

The Complaint alleges that Enzymotec, and certain of the Company's officers and underwriters, made a series of materially false and misleading statements and omissions related to the Company's business and operations in violation of the Securities Act of 1933 and the Securities Exchange Act of 1934.

Specifically, the complaint alleges that the defendants made false and misleading statements and/or failed to disclose that: (a) Enzymotec's Chinese business was subject to material and readily identifiable compliance regulations from the Chinese government; (b) the Company's Chinese baby formula business was jeopardized and subject to increased volatility and decreased revenues; (c) the Company's joint venture with AaarhusKarlshamn AB ("AAK") was crumbling and subjected the Company to liability and decreased revenues; and (4) as a result of the foregoing, the Defendants' positive statements about the Company's business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.

You may obtain a copy of the Complaint and join the class action at www.saxenawhite.com. 

If you purchased Enzymotec stock between September 27, 2013 and August 4, 2014, inclusive, you may contact Lester Hooker (lhooker@saxenawhite.com) at Saxena White P.A. to discuss your rights and interests.

If you purchased Enzymotec common stock during the Class Period of September 27, 2013 through August 4, 2014, and wish to apply to be the lead plaintiff in this action, a motion on your behalf must be filed with the Court no later than November 4, 2014. You may contact Saxena White P.A. to discuss your rights regarding the appointment of lead plaintiff and your interest in the class action. Please note that you may also retain counsel of your choice and need not take any action at this time to be a class member.

Saxena White P.A., located in Boca Raton, specializes in prosecuting securities fraud and complex class actions on behalf of institutions and individuals. Currently serving as lead counsel in numerous securities fraud class actions nationwide, the firm has recovered hundreds of millions of dollars on behalf of injured investors and is active in major litigation pending in federal and state courts throughout the United States.